PCM
WGS icon

Pentwater Capital Management’s GeneDx Holdings WGS Stock Holding History

Pentwater Capital Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,000
Closed -$2.15M – 128
2025
Q3 		$2.15M Hold
20,000
– – 0.01% 82
2025
Q2 		$1.85M Buy
+20,000
New +$1.57M 0.01% 76

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Pentwater Capital Management's WGS Position: Q2 2026 in Review

Pentwater Capital Management opened a new position in GeneDx Holdings (WGS) in Q2 2026: 82,500 shares worth $5.66M. The stake represents 0.03% of the portfolio and ranks #69 among its holdings. This is a return to the name: Pentwater Capital Management previously reported a position in WGS as recently as Q4 2025.

Pentwater Capital Management first reported a position in WGS in Q1 2025 and has held it in 5 quarters since. The position peaked at $113M in Q2 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Pentwater Capital Management held 82,500 shares of GeneDx Holdings worth $5.66M as of Q2 2026.
  • GeneDx Holdings was a new Pentwater Capital Management position in Q2 2026.
  • GeneDx Holdings made up 0.03% of Pentwater Capital Management's portfolio in Q2 2026, its #69 holding.
  • Pentwater Capital Management first reported a position in GeneDx Holdings in Q1 2025 and has held it in 5 quarters since.
  • Pentwater Capital Management's GeneDx Holdings position peaked at $113M in Q2 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Pentwater Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.